Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.61 |
| ▸ | CA9 | Q16790 | 6/20 | 0.61 |
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 4/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17287482 | 0.94 | CA2 (0.55) | CA2CA9CA1TDP1NFE2L2 | |
| SCHEMBL575589 | 0.87 | CA2 (0.52) | CA2CA9CA1CA12MMP1 | |
| SCHEMBL8890473 | 0.87 | HPGD (0.62) | CA2CA9CA1TDP1PPARG | |
| SCHEMBL9451309 | 0.80 | CA2 (0.55) | CA2CA9CA1TDP1NFE2L2 | |
| SCHEMBL28378514 | 0.80 | CA2 (0.67) | CA2CA9CA1TDP1NFE2L2 | |
| SCHEMBL3838977 | 0.80 | CA2 (0.58) | CA2CA9CA1MEN1KMT2A | |
| SCHEMBL12416930 | 0.80 | CA2 (0.57) | CA2CA9CA1NFE2L2PPARG | |
| SCHEMBL11081042 | 0.80 | CES2 (0.44) | CA2CA9CA1TDP1NFE2L2 | |
| SCHEMBL11078206 | 0.79 | NPC1 (0.60) | CA2CA9CA1PPARGMEN1 | |
| SCHEMBL168170 | 0.78 | CA2 (0.64) | CA2CA9CA1PPARGCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132148-A1 | ADJUVANT COMPOSITIONS FOR AGROCHEMICAL APPLICATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-06-26 | — | — | WO | disclosed |
| US-11897857-B2 | Isotopically-stabilized tetronimide compounds | MIDWESTERN UNIVERSITY (US) | 2024-02-13 | — | — | US | disclosed |
| CN-112839505-B | Phenylpyrazole compound and method for controlling plant disease | 住友化学株式会社 | 2023-06-06 | — | — | CN | disclosed |
| CN-110312718-B | Heterocyclene derivatives as pest control agents | 拜耳公司 | 2023-02-28 | — | — | CN | disclosed |
| US-20210094927-A1 | ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS | MIDWESTERN UNIVERSITY | 2021-04-01 | — | — | US | disclosed |
| US-10961211-B2 | Isotopically-stabilized tetronimide compounds | MIDWESTERN UNIVERSITY (US) | 2021-03-30 | — | — | US | disclosed |
| US-20200262804-A1 | Isotopically-Stabilized Tetronimide Compounds | MIDWESTERN UNIVERSITY | 2020-08-20 | — | — | US | disclosed |
| EP-3679035-A1 | NOVEL FUNGICIDAL HETEROCYCLIC COMPOUNDS | PI Industries Ltd. (IN) | 2020-07-15 | — | — | EP | disclosed |
| WO-2019048989-A1 | NOVEL FUNGICIDAL HETEROCYCLIC COMPOUNDS | PI INDUSTRIES LTD. (IN) | 2019-03-14 | — | — | WO | disclosed |
| WO-2018217042-A1 | METHOD FOR PRODUCING HIGH-QUALITY GRAPHENE FLAKE THROUGH ELECTROCHEMICAL EXFOLIATION AND SOLUTION FOR DISPERSING GRAPHENE FLAKE | 한국과학기술원 | 2018-11-29 | — | — | WO | disclosed |
| CN-100475803-C | Heterocyclic onium salt | WAKO PURE CHEM IND LTD (JP) | 2009-04-08 | — | — | CN | disclosed |
| US-7279271-B2 | Color material and silver halide color photographic light-sensitive material | KONICA MINOLTA PHOTO IMAGING INC. (JP) | 2007-10-09 | — | — | US | disclosed |
| CN-1854133-A | Heterocycle-bearing onium salts | WAKO PURE CHEM IND LTD (JP) | 2006-11-01 | — | — | CN | disclosed |
| CN-1622943-A | Heterocyclic onium salt | WAKO PURE CHEM IND LTD (JP) | 2005-06-01 | — | — | CN | disclosed |
| EP-1497317-A2 | DIPEPTIDIC GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1497316-A2 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| CN-1469871-A | Substituted dipeptides as growth hormone secretagogues | — | 2004-01-21 | — | — | CN | disclosed |
| WO-2003087070-A2 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003087069-A2 | DIPEPTIDIC GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-1998039312-A1 | STABLE ARENEDIAZONIUM SALTS, A PROCESS FOR THE PREPARATION THEREOF AND THE USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1998-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897857-B2 | Isotopically-stabilized tetronimide compounds | ASPH, BACE1, DNPEP | CA2 2174/4885CA9 2215/4885CA1 294/4885 |
| US-10961211-B2 | Isotopically-stabilized tetronimide compounds | ASPH, BACE1, DNPEP | CA2 2174/4885CA9 2215/4885CA1 294/4885 |
| US-20200262804-A1 | Isotopically-Stabilized Tetronimide Compounds | ASPH, BACE1, DNPEP | CA2 2174/4885CA9 2215/4885CA1 294/4885 |
| US-20210094927-A1 | ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS | ASPH, BACE1, DNPEP | CA2 2174/4885CA9 2215/4885CA1 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.